CoChat

Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer

Open access
Park, Jiyoung, Sarode, Venetia R., Euhus, David, Kittler, Ralf, Scherer, Philipp E. · 2012 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Poor outcomes in diabetic patients are observed across a range of human tumors, suggesting that cancer cells develop unique characteristics under diabetic conditions. Cancer cells exposed to hyperglycemic insults acquire permanent aggressive traits of tumor growth, even after a return to euglycemic conditions. Comparative genome-wide mapping of hyperglycemia-specific open chromatin regions and concomitant mRNA expression profiling revealed that the neuregulin-1 gene, encoding an established endogenous ligand for the HER3 receptor, is activated through a putative distal enhancer. Our findings highlight the targeted inhibition of NRG1-HER3 pathways as a potential target for the treatment breast cancer patients with associated diabetes.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.1214400109

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 47

Metadata

Authors
Park, J., Sarode, V. R., Euhus, D., Kittler, R., & Scherer, P. E.
Affiliations
  • Touchstone Diabetes Center and Departments of
  • Harold C. Simmons Comprehensive Cancer Center (US)
Venue
Proceedings of the National Academy of Sciences
Published
2012-12-03
Volume
109
Issue
51
Pages
21058-21063
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2030494575
Cited by
44
References
32
Citations by year
2026: 1 · 2025: 3 · 2024: 6 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 2
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
Funders
  • U.S. Department of Defense
  • Cancer Prevention and Research Institute of Texas
  • National Institutes of Health
  • National Cancer Institute (R01CA112023, BC085909, P30CA142543)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK081182, PL1DK081182, 01-DK55758, R01DK055758, P01DK088761)
  • Medical Research and Materiel Command
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
Keywords
neuregulin-1, hyperglycemia, diabetes mellitus, breast cancer, tumor aggressiveness, distal enhancers, open chromatin, gene expression profiling, therapeutic target
MeSH terms
Animals, Breast Neoplasms, Diabetes Mellitus, Gene Expression Regulation, Cricetinae, Humans, Hyperglycemia, RNA, Messenger, Tumor Cells, Cultured, Signal Transduction, CHO Cells, Genomic Imprinting, Oligonucleotide Array Sequence Analysis, Neuregulin-1, Receptor, ErbB-3, Epigenesis, Genetic, Cell Line, Tumor, Cell Proliferation, Mice, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.